Molecule to Market takes you inside the contract outsourcing space with industry insights and thoughts direct from the brains of the people that make the headlines (just think of your favourite podcast and that’s what we’re doing, but with drug supply chain shortages instead of unsolved crimes and life science leaders instead of sports stars). Talking everything from pharmaceutical contract research, development and manufacturing to clinical trial packaging, logistics and technology – Molecule to Market is a vital shot of infotainment for anyone who wants in on outsourcing.
All content for Molecule to Market: Inside the outsourcing space is the property of Raman Sehgal and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Molecule to Market takes you inside the contract outsourcing space with industry insights and thoughts direct from the brains of the people that make the headlines (just think of your favourite podcast and that’s what we’re doing, but with drug supply chain shortages instead of unsolved crimes and life science leaders instead of sports stars). Talking everything from pharmaceutical contract research, development and manufacturing to clinical trial packaging, logistics and technology – Molecule to Market is a vital shot of infotainment for anyone who wants in on outsourcing.
CDMO Live insights: Industry leaders on the future of pharma
Molecule to Market: Inside the outsourcing space
1 hour 16 minutes 29 seconds
3 months ago
CDMO Live insights: Industry leaders on the future of pharma
In this special episode of Molecule to Market, recorded at this year’s CDMO Live in Rotterdam, industry leaders come together to assess the evolving state of the contract development and manufacturing sector. Raman is the panel moderator, joined by:
Gil Roth - PBOA
Dr. Jim Li - BioDuro Sundia
Kaan-Fabian Kekec - Simon-Kucher
They unpack cautious optimism in the face of lingering market uncertainties and geopolitical tension, you’ll hear:
How CDMOs are adapting to early-stage funding strain and evolving pricing models
The impact of rising interest rates, tariffs, and global trade policy on pharma outsourcing
Capacity and talent constraints facing CDMOs in new therapeutic modalities
Why integrated models and scenario planning are key to future-proofing operations
This episode offers timely insight into the challenges and opportunities shaping the next phase of growth for CDMOs worldwide.
Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!
Molecule to Market is also sponsored by Bora Pharma (boracdmo.com) and Charles River (www.criver.com), and supported by ramarketing.
Molecule to Market: Inside the outsourcing space
Molecule to Market takes you inside the contract outsourcing space with industry insights and thoughts direct from the brains of the people that make the headlines (just think of your favourite podcast and that’s what we’re doing, but with drug supply chain shortages instead of unsolved crimes and life science leaders instead of sports stars). Talking everything from pharmaceutical contract research, development and manufacturing to clinical trial packaging, logistics and technology – Molecule to Market is a vital shot of infotainment for anyone who wants in on outsourcing.
